Description

Private equity is fueling unprecedented growth in life science tools and biotools. This session gathers leading investors to explore valuation trends, platform strategies, and M&A dynamics shaping the sector. Insights will feed into a DxPx whitepaper, positioning this discussion as a must-read for startups, strategics, and investors.